CoChat

Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis

Open access

The DOI matches its Crossref record; 171 of the 180 references it cites were found in a registry or an index.

Abstract

Matrix metalloproteinase-13 (MMP-13) is a member of the Matrix metalloproteinases (MMPs) family of endopeptidases. MMP-13 is produced in low amounts and is well-regulated during normal physiological conditions. Its expression and secretion are, however, increased in various cancers, where it plays multiple roles in tumour progression and metastasis. As an interstitial collagenase, MMP-13 can proteolytically cleave not only collagens I, II and III, but also a range of extracellular matrix proteins (ECMs). Its action causes ECM remodelling and often leads to the release of various sequestered growth and angiogenetic factors that promote tumour cell growth, invasion and angiogenesis. This review summarizes our current understanding of the regulation of MMP-13 expression and secretion and discusses the actions of MMP-13 in cancer progression and metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers14133263

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MMP-13 structure: MMP-13 consists of a highly conserved signal peptide, a pro-domain, a catalytic domain, a proline-rich hinge region and a C-terminal hemopexin-like domain (top panel). The cysteine residue (Cys 77) shown in grey within the pro-domain is linked to the catalytic zinc ion within the catalytic domain in pro-active MMP-13. The bottom panel shows the MMP-13 catalytic domain (PDB 2OW9). The structural zinc ion is in blue, the catalytic zinc ion is in green, and the three calcium ions are in orange. Three histidine residues, which bind to the catalytic zinc ion, are shown as hexagons.
Figure 1 MMP-13 structure: MMP-13 consists of a highly conserved signal peptide, a pro-domain, a catalytic domain, a proline-rich hinge region and a C-terminal hemopexin-like domain (top panel). The cysteine residue (Cys 77) shown in grey within the pro-domain is linked to the catalytic zinc ion within the catalytic domain in pro-active MMP-13. The bottom panel shows the MMP-13 catalytic domain (PDB 2OW9). The structural zinc ion is in blue, the catalytic zinc ion is in green, and the three calcium ions are in orange. Three histidine residues, which bind to the catalytic zinc ion, are shown as hexagons.CC BY · PubMed Central
Figure 2 Regulation of MMP-13 expression and secretion in pathophysiology: MMP-13 expression and secretion in physiological conditions are tightly controlled by transcription factors and TIMPs. Various transcription factors bind directly to the MMP-13 promoter region. In cancer, the tight control of MMP-13 expression is disrupted by intrinsic and extrinsic mechanisms. Intrinsic mechanisms include changes of expression of oncogenes (e.g., Ror2) and tumour suppressor genes (e.g., p53). Extrinsic mechanisms include hypoxia and inflammation-induced secretion of cytokines and chemokines that activate downstream MARK signalling and NF-κB nuclear translocation to regulate MMP-13 expression. MMP-13 secretion is regulated by endocytosis through endocytic receptor LRP1 and subsequent degradation in lysosomes.
Figure 2 Regulation of MMP-13 expression and secretion in pathophysiology: MMP-13 expression and secretion in physiological conditions are tightly controlled by transcription factors and TIMPs. Various transcription factors bind directly to the MMP-13 promoter region. In cancer, the tight control of MMP-13 expression is disrupted by intrinsic and extrinsic mechanisms. Intrinsic mechanisms include changes of expression of oncogenes (e.g., Ror2) and tumour suppressor genes (e.g., p53). Extrinsic mechanisms include hypoxia and inflammation-induced secretion of cytokines and chemokines that activate downstream MARK signalling and NF-κB nuclear translocation to regulate MMP-13 expression. MMP-13 secretion is regulated by endocytosis through endocytic receptor LRP1 and subsequent degradation in lysosomes.CC BY · PubMed Central
Figure 3 The action of MMP-13 in cancer progression and metastasis: MMP-13, produced by cancer cells and stromal fibroblasts, cleaves ECM and leads to ECM remodelling and liberation of ECM-bound growth factors and angiogenic factors that promote tumour cell proliferation, invasion, EMT and angiogenesis at primary tumour sites. At distant metastasis sites, MMP-13-mediated ECM remodelling and release of growth factors and collagen IV peptides help the recruitment of immune cells to the pre-metastatic niche and the establishment of a favourable metastasis environment.
Figure 3 The action of MMP-13 in cancer progression and metastasis: MMP-13, produced by cancer cells and stromal fibroblasts, cleaves ECM and leads to ECM remodelling and liberation of ECM-bound growth factors and angiogenic factors that promote tumour cell proliferation, invasion, EMT and angiogenesis at primary tumour sites. At distant metastasis sites, MMP-13-mediated ECM remodelling and release of growth factors and collagen IV peptides help the recruitment of immune cells to the pre-metastatic niche and the establishment of a favourable metastasis environment.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 171 references

Research works printed but not linked: 2

  1. LO, 2003, Expression and clinical significance of collagenase-3 (MMP-13) in gastric cancer, Gastroenterol. Hepatol., 26, 1
  2. Ravanti, 2000, Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder, Int. J. Cancer, 88, 417, 10.1002/1097-0215(20001101)88:3<417::aid-ijc14>3.0.co;2-g · doi:10.1002/1097-0215(20001101)88:3<417::aid-ijc14>3.0.co;2-g

Cited by

See all 92

Metadata

Authors
Li, S., Pritchard, D. M., & Yu, L.-G.
Affiliations
University of Liverpool (GB)
Corresponding author
Yu, Lu-Gang
Venue
Cancers
Publisher
MDPI AG
Published
2022-07-03
Volume
14
Issue
13
Pages
3263
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4283799682
Cited by
82
References
180
Citations by year
2026: 25 · 2025: 21 · 2024: 19 · 2023: 15 · 2022: 2
FWCI
1.72
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords
matrix metalloproteinase-13, tumor progression, metastasis, extracellular matrix remodeling, collagen degradation, angiogenesis, tumor invasion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis. https://app.cochat.ai/papers/10.3390/cancers14133263
The paper
Li, S., Pritchard, D. M., & Yu, L.-G. (2022). Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis. Cancers. https://doi.org/10.3390/cancers14133263

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.